Multiple Manufacturers

HIZENTRA

Manufacturer:

Multiple Manufacturers

Hizentra HCPCS:

J1559

HCPCS Code Descriptor:

Injection, immune globulin (hizentra), 100 mg

Category:

J Code

Hizentra NDCs:

44206-0455-10, 44206-0455-10, 44206-0454-04, 44206-0458-24, 44206-0458-24, 44206-0454-04, 44206-0452-02, 44206-0457-22, 44206-0457-22, 44206-0452-02, 44206-0451-01, 44206-0451-01, 44206-0456-21, 44206-0456-21

Primary Type:

Immunoglobulin

Generic/Specialty Status:

Multi-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Hizentra:

HIZENTRA is an Immunoglobulin drug manufactured by CSL Behring and administered via the Subcutaneous route of administration. The J Code: J1559 is aligned to the drug HIZENTRA.

Hizentra is used to aid the body's immune system in defense against infection using antibodies from healthy human blood plasma. This drug is administered via subcutaneous infusion as opposed to intravenous infusion. This means that patients are able to self-administer Hizentra by infusing under the skin. Patient support for this drug is provided by CSL Behring.

ACCESS PRICING AND MORE BY REGISTERING

J1559 Added Date:

January 1, 2011

J1559 Effective Date:

January 1, 2011

J1559 Termination Date:

HCPCS Active

Hizentra billing and coding information can be found through Csl Behring at the link below:
Hizentra patient assistance information can be found through Hizentra Connect at the URL: https://www.hizentra.com/hcp/hizentra-connect-support
HIZENTRA prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for HIZENTRA. Please check back in a few weeks.